Related Experiment Videos

[Genetics of dilated cardiomyopathy]

L Thierfelder1

  • 1Max-Delbrück-Centrum für Molekulare Medizin, Humboldt-Universität zu Berlin. lthier@mdc-berlin.de

Medizinische Klinik (Munich, Germany : 1983)
|May 22, 1998
PubMed

Insights

Dilated cardiomyopathy (DCM) is a heart muscle disorder with varied causes, including genetic factors. About 20-35% of DCM cases result from inherited gene defects, often autosomal dominant.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Context:

  • Dilated cardiomyopathy (DCM) presents with cardiac dilatation and impaired systolic function.
  • Etiologies for DCM are diverse, including viral, immunological, toxic, and genetic factors.
  • Genetic forms account for 20-35% of DCM cases, predominantly autosomal dominant.

Purpose:

  • To review the clinical presentation and genetic basis of dilated cardiomyopathy.
  • To highlight the known genetic loci and the ongoing search for causative genes.
  • To discuss the rare X-linked form of DCM linked to dystrophin gene mutations.

Summary:

  • DCM is characterized by enlarged ventricles and reduced pumping function, with varied clinical manifestations.
  • While many DCM cases have identifiable causes, a significant portion is inherited.
  • Six dominant DCM loci are known, but specific genes remain elusive; X-linked DCM involves dystrophin mutations.

Impact:

  • Understanding the genetic underpinnings of DCM is crucial for diagnosis and potential therapeutic strategies.
  • Identification of causative genes will improve genetic counseling and risk assessment for affected families.
  • Further research into DCM genetics may reveal novel pathways for heart muscle disease treatment.

Related Concept Videos